Cost consequences of task-shifting intravitreal injections from physicians to nurses in a tertiary hospital in Norway

Abstract Background Anti-vascular endothelial growth factor is a medicine administered intravitreally by an injection to maintain visual acuity in patients with a variety of retinal diseases. The demand for this treatment has grown considerably in the westernized world the last two decades and will...

Full description

Bibliographic Details
Main Authors: Stine Bolme, Dordi Austeng, Tora Sund Morken, Turid Follestad, Vidar Halsteinli
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Health Services Research
Subjects:
Online Access:https://doi.org/10.1186/s12913-023-09186-0